Article metrics

Download PDFPDF

Extended report
Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study

 

Online download statistics by month:

Online download statistics by month: May 2016 to December 2020

AbstractFullPdf
May 20161538325541
Jun 2016649275191
Jul 2016230146109
Aug 20161117978
Sep 2016887772
Oct 2016879289
Nov 20161099488
Dec 20161325123262
Jan 2017917133165
Feb 2017824263
Mar 201778463
Apr 2017615564
May 2017018272
Jun 20172710545
Jul 201713313340
Aug 201713013035
Sep 2017949435
Oct 201710410433
Nov 20171009744
Dec 2017979522
Jan 201811411439
Feb 201813212854
Mar 201811611330
Apr 2018989832
May 2018828527
Jun 2018929439
Jul 2018949426
Aug 2018737415
Sep 2018575726
Oct 2018575720
Nov 2018787820
Dec 20181009926
Jan 2019979510
Feb 2019798013
Mar 2019757633
Apr 2019626139
May 2019494926
Jun 2019656521
Jul 2019625916
Aug 2019847215
Sep 2019727116
Oct 2019757128
Nov 2019484625
Dec 2019676422
Jan 2020837723
Feb 2020716522
Mar 2020554719
Apr 2020524322
May 2020957939
Jun 2020737125
Jul 2020716830
Aug 2020453920
Sep 2020806725
Oct 20201049643
Nov 2020989024
Dec 2020716618
Total866052733039